{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:22:31Z","timestamp":1788355351634,"version":"build-2803163510"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD18\/00105"],"award-info":[{"award-number":["CD18\/00105"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ICI20\/00063"],"award-info":[{"award-number":["ICI20\/00063"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00495"],"award-info":[{"award-number":["PI18\/00495"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00506"],"award-info":[{"award-number":["PI18\/00506"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00189"],"award-info":[{"award-number":["PI21\/00189"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"Consejer\u00eda de Sanidad, Comunidad de Madrid","doi-asserted-by":"publisher","award":["EXOHEP-CM. B2017\/BMD3727"],"award-info":[{"award-number":["EXOHEP-CM. B2017\/BMD3727"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["H2020-MSCA-IF-2020- 101028834"],"award-info":[{"award-number":["H2020-MSCA-IF-2020- 101028834"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Kidney transplantation is the most common solid organ transplant and the preferred treatment for pediatric patients with end-stage renal disease, but it is still not a definitive solution due to immune graft rejection. Regulatory T cells (Treg) and their control over effector T cells is a crucial and intrinsic tolerance mechanism in limiting excessive immune responses. In the case of transplants, Treg are important for the survival of the transplanted organ, and their dysregulation could increase the risk of rejection in transplanted children. Chronic immunosuppression to prevent rejection, for which Treg are especially sensitive, have a detrimental effect on Treg counts, decreasing the Treg\/T-effector balance. Cell therapy with Treg cells is a promising approach to restore this imbalance, promoting tolerance and thus increasing graft survival. However, the strategies used to date that employ peripheral blood as a Treg source have shown limited efficacy. Moreover, it is not possible to use this approach in pediatric patients due to the limited volume of blood that can be extracted from children. Here, we outline our innovative strategy that employs the thymus removed during pediatric cardiac surgeries as a source of therapeutic Treg that could make this therapy accessible to transplanted children. The advantageous properties and the massive amount of Treg cells obtained from pediatric thymic tissue (thyTreg) opens a new possibility for Treg therapies to prevent rejection in pediatric kidney transplants. We are recruiting patients in a clinical trial to prevent rejection in heart-transplanted children through the infusion of autologous thyTreg cells (NCT04924491). If its efficacy is confirmed, thyTreg therapy may establish a new paradigm in preventing organ rejection in pediatric transplants, and their allogeneic use would extend its application to other solid organ transplantation.<\/jats:p>","DOI":"10.3389\/fped.2022.862807","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T07:13:17Z","timestamp":1652253197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation"],"prefix":"10.3389","volume":"10","author":[{"given":"Esther","family":"Bernaldo-de-Quir\u00f3s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Pion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mart\u00ednez-Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Correa-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/MOT.0000000000000783","article-title":"Pediatric kidney transplantation in the United States","volume":"25","author":"Etesami","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 annual data report: kidney","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pcl.2018.09.008","article-title":"Long-term outcomes of kidney transplantation in children","volume":"66","author":"Winterberg","year":"2019","journal-title":"Pediatr Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/cei.12978","article-title":"Regulatory T cells: tolerance induction in solid organ transplantation","volume":"189","author":"Vaikunthanathan","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cmi.2014.52","article-title":"Tolerogenic dendritic cells and their applications in transplantation","volume":"12","author":"Li","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1172\/JCI41628","article-title":"Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice","volume":"120","author":"Garcia","year":"2010","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1084\/jem.20060603","article-title":"NK cells promote transplant tolerance by killing donor antigen-presenting cells","volume":"203","author":"Yu","year":"2006","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1111\/ajt.13904","article-title":"Transcriptomic signature of the CD24(hi) CD38(hi) transitional B cells associated with an immunoregulatory phenotype in renal transplant recipients","volume":"16","author":"Bigot","year":"2016","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"662441","DOI":"10.3389\/fimmu.2021.662441","article-title":"Efficacy and safety of bone marrow-derived mesenchymal stem cells for chronic antibody-mediated rejection after kidney transplantation- a single-arm, two-dosing-regimen, phase I\/II study","volume":"12","author":"Wei","year":"2021","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2018.00585","article-title":"Regulatory T-cells: potential regulator of tissue repair and regeneration","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ki.2009.259","article-title":"Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury","volume":"76","author":"Gandolfo","year":"2009","journal-title":"Kidney Int"},{"key":"B12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cellimm.2014.04.002","article-title":"Protective effect of CD4(+)CD25(high)CD127(low) regulatory T cells in renal ischemia-reperfusion injury","volume":"289","author":"Jun","year":"2014","journal-title":"Cell Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1182\/blood-2004-01-0005","article-title":"Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes","volume":"103","author":"Joffre","year":"2004","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1111\/j.1600-6143.2012.04143.x","article-title":"Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells","volume":"12","author":"Siepert","year":"2012","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.4049\/jimmunol.179.7.4901","article-title":"Achieving donor-specific hyporesponsiveness is associated with FOXP3+ regulatory T cell recruitment in human renal allograft infiltrates","volume":"179","author":"Bestard","year":"2007","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1111\/j.1600-6143.2004.00611.x","article-title":"Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation","volume":"4","author":"Li","year":"2004","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1432-2277.2011.01389.x","article-title":"Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match","volume":"25","author":"Ohe","year":"2012","journal-title":"Transpl Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/petr.12079","article-title":"Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression","volume":"17","author":"Schulz-Juergensen","year":"2013","journal-title":"Pediatr Transplant"},{"key":"B24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1440-1797.2012.01578.x","article-title":"Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations","volume":"17","author":"Lin","year":"2012","journal-title":"Nephrology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.transproceed.2011.12.014","article-title":"Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts","volume":"44","author":"Liu","year":"2012","journal-title":"Transplant Proc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","article-title":"Contrasting CD25hiCD4+T cells\/FOXP3 patterns in chronic rejection and operational drug-free tolerance","volume":"81","author":"Louis","year":"2006","journal-title":"Transplantation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1097\/TXD.0000000000000871","article-title":"Regulatory T-cell number in peripheral blood at 1 year posttransplant as predictor of long-term kidney graft survival","volume":"5","author":"San Segundo","year":"2019","journal-title":"Transplant Direct"},{"key":"B28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nri1027","article-title":"Regulatory T cells in transplantation tolerance","volume":"3","author":"Wood","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.trre.2010.04.002","article-title":"T regulatory cells and transplantation tolerance","volume":"24","author":"Gorantla","year":"2010","journal-title":"Transplant Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12865-015-0118-8","article-title":"The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients","volume":"16","author":"Ma","year":"2015","journal-title":"BMC Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"i29","DOI":"10.1093\/bja\/aer384","article-title":"Organ transplantation: historical perspective and current practice","volume":"108","author":"Watson","year":"2012","journal-title":"Br J Anaesth"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/00007890-199712270-00012","article-title":"Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts","volume":"64","author":"Kovarik","year":"1997","journal-title":"Transplantation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1097\/TP.0000000000001379","article-title":"Impact of Immune-Modulatory Drugs on Regulatory T Cell","volume":"100","author":"Furukawa","year":"2016"},{"key":"B34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","article-title":"T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells","volume":"241","author":"Cheng","year":"2011","journal-title":"Immunol Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41598-020-80567-9","article-title":"Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation","volume":"11","author":"Lopez-Abente","year":"2021","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1111\/j.1600-6143.2012.04269.x","article-title":"Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients","volume":"12","author":"Akimova","year":"2012","journal-title":"Am J Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000313940","article-title":"Different immunosuppressive combinations on T-cell regulation in renal transplant recipients","volume":"32","author":"Fourtounas","year":"2010","journal-title":"Am J Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1097\/TP.0b013e3181d3c9d4","article-title":"Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation","volume":"89","author":"Lim","year":"2010","journal-title":"Transplantation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1097\/TXD.0000000000001152","article-title":"The presence of a marked imbalance between regulatory T cells and effector T cells reveals that tolerance mechanisms could be compromised in heart transplant children","volume":"7","author":"Bernaldo-de-Quiros","year":"2021","journal-title":"Transplant Direct"},{"key":"B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11882-010-0161-8","article-title":"The impact of vitamin D on regulatory T cells","volume":"11","author":"Chambers","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/TP.0000000000000055","article-title":"Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients","volume":"98","author":"Lee","year":"2014","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"105811","DOI":"10.1016\/j.intimp.2019.105811","article-title":"Vitamin D supplementation could reduce the risk of acute cellular rejection and infection in vitamin D deficient liver allograft recipients","volume":"75","author":"Zhou","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e01099","DOI":"10.1002\/cti2.1099","article-title":"Regulatory T cells in solid organ transplantation","volume":"9","author":"Atif","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/tri.12909","article-title":"Treg therapy in transplantation: a general overview","volume":"30","author":"Romano","year":"2017","journal-title":"Transpl Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12967-014-0331-x","article-title":"Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients","volume":"12","author":"Reinders","year":"2014","journal-title":"J Transl Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","first-page":"659621","DOI":"10.3389\/fimmu.2021.659621","article-title":"The unique immunomodulatory properties of MSC-derived exosomes in organ transplantation","volume":"12","author":"Zheng","year":"2021","journal-title":"Front"},{"key":"B48","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MOT.0b013e328355a992","article-title":"Regulatory T-cell therapy for transplantation: how many cells do we need?","volume":"17","author":"Tang","year":"2012","journal-title":"Curr Opin Organ Transplant"},{"key":"B49","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1172\/JCI42933","article-title":"Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation","volume":"120","author":"Schreiber","year":"2010","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/ajt.16940","article-title":"Tumor necrosis factor receptor superfamily member 25 (TNFRSF25) agonists in islet transplantation: endogenous in vivo regulatory T cell expansion promotes prolonged allograft survival","volume":"22","author":"Marfil-Garza","year":"2021","journal-title":"Am J Transplant"},{"key":"B52","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.trim.2009.05.003","article-title":"Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression","volume":"21","author":"Tsang","year":"2009","journal-title":"Transpl Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1172\/JCI23743","article-title":"Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates","volume":"115","author":"Bashuda","year":"2005","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.intimp.2010.11.001","article-title":"Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys","volume":"11","author":"Ma","year":"2011","journal-title":"Int Immunopharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/TP.0000000000001559","article-title":"Effect of ex vivo-expanded recipient regulatory T cells on hematopoietic chimerism and kidney allograft tolerance across MHC barriers in cynomolgus macaques","volume":"101","author":"Duran-Struuck","year":"2017","journal-title":"Transplantation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1097\/TP.0b013e3181ff8772","article-title":"Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model","volume":"90","author":"Issa","year":"2010","journal-title":"Transplantation"},{"key":"B57","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/TP.0b013e31829fa271","article-title":"Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model","volume":"96","author":"Wu","year":"2013","journal-title":"Transplantation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nm.2154","article-title":"In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells","volume":"16","author":"Nadig","year":"2010","journal-title":"Nat Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.2215\/CJN.01750218","article-title":"Regulatory T cells and kidney transplantation","volume":"13","author":"Martin-Moreno","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"631365","DOI":"10.3389\/fimmu.2021.631365","article-title":"Adoptive transfer of regulatory immune cells in organ transplantation","volume":"12","author":"Oberholtzer","year":"2021","journal-title":"Front Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","article-title":"Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants","volume":"17","author":"Chandran","year":"2017","journal-title":"Am J Transplant"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I clinical trial with ex vivo expanded recipient regulatory t cells in living donor kidney transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","first-page":"m3734","DOI":"10.1136\/bmj.m3734","article-title":"Regulatory T cells for minimising immune suppression in kidney transplantation: phase I\/IIa clinical trial","volume":"371","author":"Roemhild","year":"2020","journal-title":"BMJ"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/ajt.16395","article-title":"Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients","volume":"21","author":"Harden","year":"2021","journal-title":"Am J Transplant"},{"key":"B66","first-page":"81","article-title":"Tumor-infiltrating regulatory T cells: origins and features","volume":"7","author":"Deng","year":"2018","journal-title":"Am J Clin Exp Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ki.2013.538","article-title":"The immune phenotype may relate to cancer development in kidney transplant recipients","volume":"86","author":"Hope","year":"2014","journal-title":"Kidney Int"},{"key":"B68","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"Sanchez-Fueyo","year":"2020","journal-title":"Am J Transplant"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"744763","DOI":"10.3389\/fimmu.2021.744763","article-title":"Polyclonal regulatory T cell manufacturing under cGMP: a decade of experience","volume":"12","author":"Balcerek","year":"2021","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur J Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-60761-869-0_2","article-title":"Polyclonal expansion of human CD4(+)CD25(+) regulatory T cells","volume":"677","author":"Hoffmann","year":"2011","journal-title":"Methods Mol Biol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/gutjnl-2014-306919","article-title":"Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease","volume":"65","author":"Canavan","year":"2016","journal-title":"Gut"},{"key":"B77","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"key":"B78","first-page":"1","volume-title":"Maximum Blood Draw Limits","year":"2014"},{"key":"B79","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1365-3083.2012.02671.x","article-title":"Paediatric reference values for the peripheral T cell compartment","volume":"75","author":"Schatorje","year":"2012","journal-title":"Scand J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3389\/fimmu.2020.00611","article-title":"Human regulatory T cells from umbilical cord blood display increased repertoire diversity and lineage stability relative to adult peripheral blood","volume":"11","author":"Motwani","year":"2020","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: take a billion or so and call me in the morning","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"B84","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fimmu.2015.00395","article-title":"Regulatory T-cell development in the human thymus","volume":"6","author":"Caramalho","year":"2015","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/ajt.13456","article-title":"Discarded human thymus is a novel source of stable and long-lived therapeutic regulatory t cells","volume":"16","author":"Dijke","year":"2016","journal-title":"Am J Transplant"},{"key":"B86","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.1097\/01.tp.0000542859.38902.af","article-title":"\u201cFirst-In-Human\u201d Clinical trial employing adoptive transfer of autologous thymus-derived treg cells (thyTreg) to prevent graft rejection in heart-transplanted children","volume":"102","author":"Bernaldo-de-Quir\u00f3s","year":"2018","journal-title":"Transplantation"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.862807\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T21:54:15Z","timestamp":1675547655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.862807\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":86,"alternative-id":["10.3389\/fped.2022.862807"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.862807","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"862807"}}